PRIMARY EFFUSION LYMPHOMA
Clinical trials for PRIMARY EFFUSION LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY EFFUSION LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY EFFUSION LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new oral drug called SGR-1505 in adults with various types of relapsed or hard-to-treat B-cell cancers, like non-Hodgkin lymphoma and chronic lymphocytic leukemia. The main goal is to find the highest dose patients can tolera…
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists seek donors to unlock secrets of HIV and cancer
Knowledge-focused Recruiting nowThis study is collecting blood, bone marrow, and tissue samples from people with HIV or certain virus-related cancers. The goal is to help researchers better understand how these diseases work, which could lead to future treatments. Participants will provide samples but will not …
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC